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The ultraviolet radiation present in sunlight is the
primary cause of nonmelanoma skin cancer and has
been implicated in the development of cutaneous
malignant melanoma. In addition, ultraviolet is
immune suppressive and the suppression induced by
ultraviolet radiation has been identi®ed as a risk fac-
tor for skin cancer induction. Ultraviolet also sup-
presses the immune response to infectious agents. In
most experimental models, ultraviolet is applied to
immunologically naive animals prior to immuniza-
tion. Of equal concern, however, is the ability of
sunlight to suppress established immune reactions,
such as the recall reaction in humans, which protects
against microbial infections. Here we demonstrate
that solar-simulated ultraviolet radiation, applied
after immunization, suppresses immunologic mem-
ory and the elicitation of delayed-type hypersensitiv-
ity. Further, we found that wavelengths in the
ultraviolet A region of the solar spectrum were crit-
ical for inducing immune suppression. Ultraviolet A
(320±400 nm) radiation was as effective as solar-
simulated ultraviolet A + B (290±400 nm) in sup-
pressing the elicitation of an established immune
response. Irradiation with ultraviolet AI (340±
400 nm) had no effect. Supporting a critical role for
ultraviolet A in ultraviolet-induced immune suppres-
sion was the observation that applying a sunscreen
that contained an ultraviolet B only ®lter had no
protective effect, whereas, a sunscreen containing
both ultraviolet A and ultraviolet B ®lters totally
blocked ultraviolet-induced immune suppression.
These data suggest that sunlight may depress the
protective effect of prior vaccination. In addition,
the observation that ultraviolet A is immunosuppres-
sive indicates the need for ultraviolet A protection
when designing sun protection strategies. Key words:
delayed type hypersensitivity/immune suppression/skin can-
cer/solar-simulated ultraviolet radiation. J Invest Dermatol
117:1193±1199, 2001
T
he ultraviolet (UV) radiation present in sunlight is a
complete carcinogen and the primary cause of
nonmelanoma skin cancer (Urbach, 1997). UV
radiation has also been implicated in the induction
of cutaneous malignant melanoma (Setlow et al, 1993;
Dooley, 1994). In addition to skin cancer formation, UV exposure
causes cataract formation, sunburn, premature aging of the skin,
activation of latent viruses, and immune suppression (reviewed by
Ullrich, 2000). The immune suppressive effects of UV radiation
contribute to skin cancer development by depressing cell-mediated
immune reactions that normally serve to destroy the developing
skin tumors. Epidemiologic studies with immune-suppressed renal
transplant patients (Penn, 1984), experiments with laboratory mice
(Fisher and Kripke, 1982), and immunologic studies with skin
cancer patients (Yoshikawa et al, 1990), support the hypothesis that
the immune suppression induced by UV exposure is a major risk
factor for skin cancer induction.
In addition, UV exposure suppresses immune responses to
infectious organisms (Jeevan et al, 1992). In the majority of studies
documenting UV-induced suppression of the immune response to
microbial and viral agents, the UV was administered to naive
animals prior to immunization (i.e, suppressing the induction of
immunity). Of equal concern, however, is the ability of UV
exposure to suppress established immune responses. Perhaps the
most important medical advance of the twentieth century was the
reduction, and in some cases the eradication (i.e, smallpox) of
certain microbial infections through the widespread use of
childhood vaccinations. Because UV radiation can suppress the
elicitation of certain immune responses (Denkins et al, 1989; Magee
et al, 1989; Moyal et al, 1997), sunlight exposure may compromise
the ability of prior vaccination to control infectious disease.
Unfortunately, little is known concerning the underlying im-
munologic mechanism(s) of UV-induced suppression of an estab-
lished immune response.
Furthermore, little is known about the basic photobiologic
mechanisms involved. Ambient UV radiation is divided into two
major regions: (i) UVB (290±320 nm), which comprises less than
5% of the UV that reaches the biosphere, and (ii) UVA (320±400),
which comprises at least 95% of the remaining UV radiation.
Although the role of UVB in inducing skin cancer and immune
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suppression is well known, the contribution of UVA to the
deleterious effects of sunlight are not as well de®ned. The action
spectrum for melanoma induction in Xiphophorus implicates UVA
in melanoma induction (Setlow et al, 1993). Whether this action
spectrum also applies to melanoma induction in humans remains to
be seen. Similarly, the scienti®c literature concerning the role of
UVA in UV-induced immune suppression is contradictory.
Examples of UVA suppressing the induction of immunity
(Hersey et al, 1983, 1988; Bestak and Halliday, 1996; Damian
et al, 1997; LeVee et al, 1997) are as numerous as examples where
UVA fails to have an effect (Sjovall and Christensen, 1986; Skov
et al, 1997, 1998; Reeve et al, 1998, 1999). Moreover, recent
reports from Reeve and colleagues suggest that prior exposure to
UVA radiation can protect against the immunosuppressive effects
of UVB (Reeve et al, 1998; Shen et al, 1999).
Determining the relative role of UVA in immune suppression
may have broad implications besides being of interest to photo-
immunologists. Oncologists and dermatologists have been promot-
ing a campaign of `safe sun exposure' to combat the dramatic rise in
skin cancer incidence. Using sunscreens is an essential part of this
campaign. Until very recently, most sunscreens available in the
United States absorbed wavelengths in the UVB region of the solar
spectrum, with little or no absorption in the UVA region. This
appears to be suf®cient to protect against sunlight-induced p53
mutations and nonmelanoma skin cancer induction
(Ananthaswamy et al, 1997, 1999); however, the action spectrum
for melanoma induction in ®sh, and data suggesting that UVA
induces immune suppression raise concerns about the ability of
most sunscreens to provide adequate UVA protection. On the
other hand, the provocative data presented by Reeve et al, 1998,
questions whether it is even desirable to add UVA ®lters to
sunscreens. It is extremely important, therefore, to clarify the role
of solar UVA in immune suppression and other forms of
photodamage.
MATERIALS AND METHODS
Animals Speci®c pathogen-free female C3H/HeNCr (MTV±) mice
were obtained from the National Cancer Institute Frederick Cancer
Research Facility Animal Production Area (Frederick, MD). The animals
were maintained in facilities approved by the Association for Assessment
and Accreditation of Laboratory Animal Care International, in
accordance with current regulations and standards of the National
Institutes of Health. All animal procedures were reviewed and approved
by the Institutional Animal Care and Use Committee. Within each
experiment all the mice were age matched. The mice were 8±10 wk old
at the start of each experiment.
Radiation source A 1000 W Xenon UV solar simulator equipped
with a Schott WG-320 atmospheric attenuation ®lter (1 mm thick), a
visible/infrared bandpass blocking ®lter (Schott UG-11; 1 mm thick) and
a dichroic mirror to further reduce visible and infrared energy (Oriel
Corp. Stratford, CT) was used to provide solar-simulated UV radiation
(Fig 1; WG-320). Replacing the WG-320 ®lter with a 3 mm thick
WG-335 ®lter resulted in a UVA source de®cient in UVB (Fig 1; WG-
335). Replacing the WG-320 ®lter with a 2 mm thick WG-360 ®lter
resulted in a UV source devoid of UVB and de®cient in UVA II (Fig 1;
WG-360). The WG-320 and WG-335 ®lters were purchased from Oriel
Corp. The Schott WG-360 ®lter was generously provided to us by Dr
F. J. Christiaens, L'OreÂal, Clichy, France. The intensity and the spectral
output of the solar simulator was measured with an Optronics model OL
754 scanning spectrophotometer interfaced to an Acer model 330
notebook computer (Optronics Laboratories, Orlando, FL). During
irradiation, the mice were held individually in a specially constructed
Plexiglas container with a quartz glass top, to prevent cage mates from
climbing on top of each other and interfering with the UV dose applied.
Spectrophotometer readings were taken through the quartz glass top.
During the irradiation period (15±90 min in duration) the mice were
conscious and had a full range of movement.
Suppression of immunologic memory and established immune
responses by UV radiation Female C3H/HeN mice were immunized
by subcutaneous injection of 107 formalin-®xed Candida albicans into
each ¯ank (Moodycliffe et al, 2000). Seven days later the mice were
boosted with an identical dose of C. albicans into each ¯ank. Thirty days
later the mice were shaved and exposed to solar-simulated UV radiation
as described previously (Ananthaswamy et al, 1997). The next day each
hind footpad was measured with an engineer's micrometer (Mitutoyo,
Tokyo, Japan) and then challenged by intrafootpad injection of 50 ml of
Candida antigen (Alerchek Inc, Portland, ME). Eighteen to 24 h later the
thickness of each foot was re-measured and the mean footpad thickness
for each mouse was calculated (left foot + right foot 4 2). Generally,
there were ®ve mice per group, the mean footpad thickness for the
group 6 SEM was calculated. The background footpad swelling
(negative control) was determined in a group of mice that were not
immunized but were challenged. The speci®c footpad swelling response
was calculated by subtracting the background response observed in the
negative controls from the mean footpad swelling found in mice that
were immunized and challenged. Each experiment was repeated at least
three times. Statistical differences between the controls and experimental
groups were determined by using the two-tailed Student's t test, where
p < 0.05 was considered signi®cant (Prism Statistical Software, GraphPad
Inc, San Diego, CA). Percentage immune suppression was determined
by the following formula: % immune suppression = (1 ± {speci®c
footpad swelling of the UV-irradiated mice 4 speci®c footpad swelling
of the positive control} 3 100).
To determine if UV radiation suppresses the elicitation of delayed type
hypersensitivity (DTH) mice were immunized by the subcutaneous
injection of 107 formalin-®xed C. albicans, as described above. Nine days
later the immunized mice were shaved and their dorsal skin was exposed
to solar-simulated UV radiation. The next day each hind footpad was
measured and challenged by intrafootpad injection of 50 ml of Candida
antigen. Footpad swelling was read 18±24 h later.
Sunscreen formulations Two SPF 15 sunscreens were used in these
studies, a predominantly UVB absorber (P532) and a sunscreen that
equally absorbs both UVA and UVB radiation (P533). The UV
absorption spectra of the sunscreens and their chemical composition were
reported previously (Ananthaswamy et al, 1999). The vehicle, an oil-in-
water emulsion, was the same for both sunscreen preparations. The
sunscreens and the vehicle were applied to the shaved dorsal skin of the
mice (100 ml per mouse: » 2 mg per cm2) 30 min prior to irradiation, as
described previously (Ananthaswamy et al, 1999).
RESULTS
Solar-simulated UV radiation suppresses established
immune responses First we measured the effect of UV
radiation on immunologic memory. Formalin-®xed C. albicans
was injected on days 0 and 7 as described above. Thirty days after
the second immunization, the mice were exposed to 120 kJ per m2
of UVA + B radiation (WG 320-®ltered solar simulator). The mice
were challenged with antigen on the next day, and DTH was
measured 18 h later. As shown in Fig 2A, exposing mice to UV
radiation 30 d postimmunization, signi®cantly suppressed
immunologic memory (60% immune suppression; p < 0.05 vs the
positive control).
Next we measured the effect that UV radiation had on the
elicitation of DTH. In these experiments, the mice were
immunized with C. albicans on day 0, exposed to UV on day 9,
challenged with antigen on day 10. DTH was read 18 h later.
Results obtained when mice were exposed to UVA + B radiation
(WG-320 ®ltered solar simulator) are shown in Fig 2(B).
Signi®cant immune suppression (p < 0.01) was observed with
doses equal to, or in excess of 60 kJ per m2 of UV radiation (290±
400 nm). Similar results were obtained when mice were irradiated
with a solar simulator equipped with a Schott WG-335 ®lter that
effectively removes UVB radiation (Fig 2C). Compared with the
positive control, signi®cant immune suppression (p < 0.01) was
observed with doses equal to, or in excess of 60 kJ per m2 of UVA
radiation (320±400 nm). These ®ndings indicate that UV radiation
suppresses established immune reactions and that the critical
wavelengths reside within the UVA region of the solar spectrum.
For the sake of comparison the D footpad swelling data presented
in Fig 2(B, C) were converted into percentage immune suppres-
sion and plotted vs the dose of UV applied. These data are found in
Fig 3. There was a highly signi®cant correlation (p < 0.001;
Pearson correlation test) between the suppression induced by the
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WG 320-®ltered solar simulator and the WG 335-®ltered solar
simulator. In addition, the amount of UV radiation required to
generate 50% immune suppression was identical when a combin-
ation of UVB and UVA (WG 320), or UVA de®cient in UVB
(WG 335), was used to suppress the elicitation of DTH (80 kJ per
m2 UVA + B; r2 = 0.976 vs 82 kJ per m2 UVA; r2 = 0.983).
In the next series of experiments mice were exposed to UV
radiation from a solar simulator equipped with a WG-360 ®lter
(Table I). This ®lter removes all the UVB radiation and most of
the UVA II (320±340) radiation. Unlike the results presented
above, irradiation with a source devoid of UVB, de®cient in UVA
II and rich in UVA I radiation, failed to suppress the elicitation of
DTH. These data (Fig 2B,C and Table I) indicate that wave-
lengths in the UVA II region of the solar spectrum (320±340 nm)
are responsible for suppressing established immune reactions.
These data imply that the UVA in solar-simulated radiation is
solely responsible for suppressing the elicitation of DTH to the
fungal antigen, C. albicans. We decided to test this hypothesis
further by measuring the protective effect of two sunscreens in our
experiments. The ®rst P533, absorbs both UVA and UVB
radiation, whereas the second, P532 absorbs wavelengths primarily
in the UVB region of the solar spectrum. Both sunscreens had a sun
protection factor of 15; as measured in humans (Ananthaswamy
et al, 1999) and hairless mice (Anny Fourtanier, L'Oreal, personal
communication). Data from this experiment are presented in
Fig 4. In Fig 4(A), the sunscreen that absorbed both UVA and
UVB (P533) was applied. The positive control in this experiment
consisted of a group of mice that were immunized with C. albicans
on day 0, painted with the vehicle on day 9, and then challenged
with antigen on day 10. The DTH reaction was measured 18±24 h
later. The negative control mice were handled in an identical
manner, but they were not immunized. Applying the sunscreen to
another group of positive and negative control mice demonstrated
that the sunscreen by itself did not have any effect on the immune
response (p > 0.05, Student's t test). We observed signi®cant (p
< 0.01) and substantial (60±80%) immune suppression when the
vehicle-treated mice were irradiated with doses equal to, or greater
Figure 2. Solar-simulated UV radiation suppresses established
immune responses. In (A), the effect of UV radiation on immunologic
memory was measured. Mice were ®rst immunized on day 0, again on
day 7 and then exposed to UV radiation (WG 320) 30 d after the
second immunization. In (B) and (C), the effect of UV radiation on the
elicitation of DTH was measured. Mice were immunized and 9 d later
treated with different amounts of UVA + B (B: WG 320) or UVA (C:
WG 335) radiation. *Signi®cant difference (p < 0.01; two-tailed
Student's t test, n = 5) vs the positive control.
Figure 1. Spectral output of the light source used in this study.
The Xenon UV source was equipped with: a WG 320/1 mm ®lter to
provide UVB + UVA radiation (WG 320); a WG 335/3 mm ®lter to
provide UVA I and II radiation (WG 335); or a WG 360/2 mm ®lter to
provide UVA I radiation (WG 360).
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than, 40 kJ per m2. When, however, the mice were treated with
the UVA + B absorbing sunscreen, no immune suppression was
observed. In all cases, the response generated in the UV + P533
sunscreen-treated mice was not signi®cantly different from the
positive control.
An entirely different situation was observed when the mice were
treated with the UVB only absorbing sunscreen (Fig 4B). Similar
to the experiment described above, application of sunscreen P532
had no effect on the generation of the immune response (vehicle
+ positive control vs P523 + positive control). Here also, we
observed signi®cant (p < 0.01) immune suppression when the mice
Table I. WG 360-®ltered SSR (UVA I) does not suppress
the elicitation of DTH to C. albicans
Treatmenta
D footpad swelling
(mm 3 10±2
6 SD)
Speci®c
swellingb
%
suppressionc pd
Negative control 1.0 6 0.9 ±
Positive control 12.1 6 1.6 11.1 0 ±
WG 320
80 kJ per m2
3.9 6 2.0 2.9 73.8 0.0006
WG 360
80 kJ per m2
11.8 6 2.5 10.8 2.7 0.847
WG 360
160 kJ per m2
12.0 6 1.9 11 0.9 0.413
aMice were immunized with C. albicans. Nine days later their shaved dorsal skin
was exposed to different doses of UV radiation from a WG-320 or WG 360-®l-
tered SSR. Ten days postimmunization they were challenged with C. albicans anti-
gen and footpad swelling was read 24 h later. Negative control refers to mice that
were not immunized but were challenged; positive control refers to mice that were
immunized and challenged.
bDfootpad swelling of experimental groups minus the background swelling found
in the negative control.
c% immune suppression = (1 ± {speci®c footpad swelling of the UV-irradiated
mice 4 speci®c footpad swelling of the positive control} 3 100).
dp-values determined by two-tailed Student's t test vs the positive control.
Figure 4. A UVA absorbing sunscreen affords immune
protection. Two different sunscreen preparations were applied to mice
30 min prior to UV exposure. (A) Application of sunscreen P533, a
UVA + B absorber blocks UV induced immune suppression
(NC = negative control; PC = positive control). (B) Application of
sunscreen P532, a UVB only absorber fails to block UV-induced
immune suppression. (C) Comparison of immune protection afforded by
UVB (P532) or UVA + B (P533) absorbing sunscreens. The percentage
immune suppression generated in the presence of the vehicle (h);
sunscreen P533 (r); or sunscreen P532 (d) was plotted vs the dose of
UV (WG-320) applied. *p < 0.01; Student's t test vs the positive
control. Individual experiments are shown, each experiment was
repeated twice with similar results.
Figure 3. Dose±response curves for suppressing the elicitation of
DTH to C. albicans. Mice were exposed to different doses of UV
radiation supplied by the WG 320-®ltered solar simulator (h) or the
WG 335-®ltered solar simulator (r). The footpad swelling for each
group was converted into percentage immune suppression and plotted vs
the dose of UV applied. The regression curves shown here were
generated using pooled data from three independent experiments.
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were exposed doses of > 40 kJ per m2 UV radiation; however,
unlike the situation described above, the UVB only absorbing
sunscreen had no protective effect. Signi®cant immune suppression
was generated regardless of whether the vehicle or sunscreen P532
was applied.
These data (Fig 4A, B) were converted to percentage immune
suppression and plotted vs the dose of UV applied (Fig 4C). From
these data it is apparent that applying the UVB only absorbing
sunscreen affords no immune protection, whereas substantial
immune protection is afforded by applying a sunscreen that absorbs
UVA radiation. These data, in conjunction with the ®ndings
presented in Fig 3, indicate that the UVA wavelengths present in
solar-simulated radiation are responsible for suppressing an estab-
lished immune response.
DISCUSSION
Although it is well recognized that UV exposure suppresses the
induction of an immune response when applied before immuniza-
tion, less is known about the effects of UV on established immune
reactions (Denkins et al, 1989; Magee et al, 1989). Perhaps the most
successful public health campaign of the twentieth century was
using vaccination to reduce the morbidity and mortality due to
infectious disease. If sunlight can suppress established immune
reactions, it may suggest that UV exposure could increase
susceptibility in immunized individuals. Because the best index of
sunlight exposure, skin cancer incidence, is on the rise (Boring et al,
1992) we suggest that increased human UV exposure has the
potential to depress vaccine ef®cacy. This hypothesis is supported
by the data presented here demonstrating that exposure to UV
radiation after immunization can suppress immunologic memory.
These ®ndings, along with studies on human volunteers demon-
strating that solar-simulated UV radiation suppresses the immune
response to recall antigens (Moyal et al, 1997), indicate that it is
critically important to study this phenomena in detail, paying
particular attention to the mechanisms involved.
In order to understand the mechanism(s) involved, it is necessary
to ®rst determine which wavelengths are responsible for immune
suppression. Although the majority of UV radiation in sunlight is
UVA, immunologists have historically concentrated on the
immunosuppressive effects of UVB radiation. This is because
wavelengths in the UVB region of the solar spectrum induce
immune suppression and skin cancer (Black et al, 1997). In regard
to immune suppression, UVA was considered to be benign because
most studies in the literature suggested that UVA did not depress
immunity (Kripke et al, 1983; Morison et al, 1985; Sjovall and
Christensen, 1986; Baadsgaard et al, 1987; Granstein et al, 1987);
however, data from more recent studies, including those presented
here, indicate that UVA radiation can suppress the immune
response (Bestak and Halliday, 1996; Damian et al, 1997, 1999;
LeVee et al, 1997). We suggest three potential explanations for
these divergent ®ndings. First, for the most part, experiments
showing no immune suppression by UVA used ¯uorescent
sunlamps as the source of radiation. Although ¯uorescent sunlamps
are excellent sources of UVB radiation, they are poor substitutes for
sunlight and their emissions, particularly in the UVA region of the
solar spectrum, differ signi®cantly from sunlight (Kim et al, 1998).
On the other hand, when solar-simulated radiation was used in the
place of ¯uorescent sunlamps, UVA was immune suppressive
(Bestak and Halliday, 1996; Damian et al, 1997, 1999; LeVee et al,
1997).
The second potential reason for the divergent ®ndings in the
literature may re¯ect the protocols used to measure immune
function. El-Ghorr and Norval (1999) report that different amounts
of UVA radiation are required to suppress different types of
immune reactions. They noted that 500 times more UVA was
needed to suppress contact allergic reactions vs DTH. Many of the
reports mentioned above, showing that UVA radiation fails to
induce immune suppression, used contact allergy as the endpoint.
Third, the different mechanisms involved in inducing local and
systemic immune suppression by UV radiation may also contribute
to the divergent ®ndings reported in the literature. For example,
when volunteers were exposed to low-dose UV radiation provided
by an alternating array of UVA and UVB ¯uorescent bulbs,
immune suppression was only observed when the antigen (puri®ed
protein derivative) was injected at the irradiated site (local
suppression). No immune suppression was noted when noted
when the PPD was injected at distant sites nonirradiated sites
(systemic suppression) (Damian et al, 1998). In the experiments
presented here, we observe systemic suppression of established
immune reactions by UVA, and this may be a function of the
higher doses of UV employed in our studies.
Regardless of the reasons for the con¯icting data reported in the
literature, our ®ndings illustrate a number of important facts. First,
we used UV radiation to suppress the elicitation of DTH and
immunologic memory to a common opportunistic pathogen. This
suggests that UV exposure may contribute to decreased vaccine
ef®cacy. Second, substantial and signi®cant suppression of an
established immune reaction was achieved with physiologic doses
of UV radiation. We achieve 50% immune suppression with 50±
80 kJ per m2 of solar-simulated UV radiation. Based on our
measurements of the intensity of solar UV radiation present in
sunlight (in September midday sun, Houston TX, 30°N latitude),
we estimate that 30 min of sunlight exposure will provide an
equivalent UV dose in humans. Because some have reported that
rodent antigen-presenting cells are three to four times more
susceptible to the immune suppressive effects of UV radiation than
human antigen-presenting cells (Goettsch et al, 1998b), care must
be employed when extrapolating results from animal models to
humans. It is interesting to note, however, that the same authors
subsequently reported that 90 min of sunlight exposure (in July,
40°N latitude) caused 50% suppression of the immune response to
Listeria monocytogenes in humans (Goettsch et al, 1998a). These
immunosuppressive doses of sunlight can easily be achieved during
normal recreational or occupational exposure.
Third, we show that UVA radiation, de®cient in UVB,
suppresses established immune reactions. The data presented in
Fig 3 demonstrate that the dose±response curves for suppressing
the elicitation of DTH by UVA + B and UVA are identical. This is
an important observation impacting on sunscreen design. There has
been a debate in the photobiologic community in regard to the
need for UVA protection to prevent immune suppression (Ullrich
et al, 1999). The reports indicating no immune suppression by
UVA suggest there is little need for UVA protection (Kripke et al,
1983; Morison et al, 1985; Sjovall and Christensen, 1986;
Baadsgaard et al, 1987; Granstein et al, 1987). On the other hand,
some have shown immune protection when broad-spectrum
sunscreens were applied before UV exposure, indicating a need
for UVA protection (Moyal et al, 1997; Fourtanier et al, 2000).
Determining the critical wavelengths required for immune sup-
pression based on differential protection with different sunscreen
formulations can be somewhat problematic. Although efforts are
made to control the amount of sunscreen applied, the area of
coverage, the skin type of the volunteers, and the sunburn
protection factor of the sunscreen, some degree of uncertainty,
especially in regard to the exact wavelengths and amount of UV
radiation that actually reach the skin remains. In our study we used
optical ®lters to achieve a three to four log reduction in the amount
of UVB in the solar-simulated radiation. This removes any
uncertainty about which wavelengths are involved. Moreover,
the requirement for UVA protection is clearly supported by our
sunscreen experiments, in which we found immune protection
only when the applied sunscreen absorbed UVA radiation. These
data provide compelling evidence for the need to protect against
UVA exposure, particularly UVA II, in order to block UV-induced
suppression of established immune reactions.
Data published by others indicate that exposure to UVA prior to
UVB can prevent immune suppression (Reeve et al, 1998, 1999;
Reeve and Tyrrell, 1999; Garssen et al 2001). Based on these
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®ndings some have suggested that a short course of UVA adaptation
before sunlight exposure can be used as a strategy for photoprotec-
tion. For this approach to be successful, UVA radiation by itself
cannot be immune suppressive. Although we have not tried to
reproduce Reeve's data directly (Reeve et al, 1998), our results
demonstrating that solar-simulated UVA is not benign and can
induce immune suppression, cautions against the use of UVA as a
natural photoprotective agent. Our data imply that UVA protec-
tion is an absolute requirement to block immune suppression.
Melanoma is the most dangerous of all skin cancers. Although
considerable evidence exists demonstrating that melanomas are
immunogenic (Donawho et al, 1996; Wang et al, 1999) they clearly
are capable of escaping immune destruction. This may be due in
part to the production of immune suppressive cytokines, such as
interleukin-10, by the melanoma cells (Dummer et al, 1996; Huang
et al, 1996). The data presented here provide new insight into the
mechanism behind the ability of melanoma to escape immune
surveillance. Setlow's melanoma action spectrum suggests a role for
UVA radiation in the induction of this disease (Setlow et al, 1993).
Furthermore, studies by Donawho et al demonstrate that UV-
induced suppression of the elicitation of the immune response is
involved in the progressive growth of transplanted melanoma cells
(Donawho and Kripke, 1991; Donawho et al, 1996). We suggest
that the UVA may be playing a dual role in melanoma develop-
ment; induction, as suggested by Setlow et al (1993) and promotion
by suppressing the immune response, as demonstrated here. If this is
true it may explain previous ®ndings indicating that UVB-
absorbing sunscreens were incapable of interfering with UV-
induced enhancement of melanoma growth in mice (Wolf et al,
1994). Whether these ®ndings (i.e, suppression of established
immune responses by UVA) may also help to explain the confusing
positive risk ratio between melanoma development in humans and
the use of sunscreens that primarily absorb UVB radiation (Wolf
et al, 1998), remains to be seen.
In summary, the data presented here demonstrate that UV
exposure suppresses immunologic memory and the elicitation of
the immune response to a common opportunistic pathogen. In
addition, we found that UVA radiation, de®cient in UVB was
effective in suppressing the elicitation of immunity. These data
suggest that sunlight-induced suppression of established immune
reactions may serve as a risk factor for increased susceptibility to
infectious agents. Moreover, they clearly indicate the need for
UVA protection in blocking sunlight-induced immune suppres-
sion.
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